Search filters

List of works by Mark G. Lebwohl

6-thioguanine in the treatment of psoriasis: a case report and literature review

scientific article

A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structure

article

A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis

scientific article published on 19 September 2014

A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis

scientific article

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Ammonium Lactate Lotion 12% and Halobetasol Propionate Ointment 0.05% in the Treatment and Maintenance of Psoriasis ⬇️

scientific article published on February 1, 2011

A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis

scientific article published on July 1, 2011

A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA).

scientific article

A clinician's paradigm in the treatment of psoriasis

scientific article

A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis.

scientific article published on 10 April 2015

A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis

scientific article published on 01 March 1991

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis

scientific article

A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis

scientific article published on 01 August 1996

A novel targeted T-cell modulator, efalizumab, for plaque psoriasis

scientific article published on 01 November 2003

A preliminary 18F-FDG-PET/MRI study shows increased vascular inflammation in moderate-to-severe atopic dermatitis

scientific article published on 25 July 2020

A randomized controlled trial of oral phosphate binders in the treatment of pseudoxanthoma elasticum

scientific article

A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata

scientific article published on 11 November 2018

A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis ⬇️

scientific article published on May 1, 2013

A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis

scientific article published in May 2002

A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses

scientific article published on September 1, 2010

A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes

scientific article published in October 2006

A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses.

scientific article published in June 2008

A systematic review of safety and efficacy of systemic corticosteroids in atopic dermatitis

scientific article published on 12 October 2017

AAD consensus statement on psoriasis therapies ⬇️

scientific article published on November 1, 2003

Abnormalities of connective tissue components in lesional and non-lesional tissue of patients with pseudoxanthoma elasticum

scientific article published in January 1993

Abnormalities of fibrillin in acquired cutis laxa

scientific article published on 01 June 1994

Acanthosis nigricans in a plaque of scleredema on the back of a diabetic patient: a case report

scientific article published on 01 January 2005

Adherence to topical therapies in actinic keratosis: A literature review

scientific article published on 10 May 2016

Advances in first-line topical therapies: the role of a 2-compound ointment for psoriasis vulgaris

scientific article published on 01 January 2007

Advances in psoriasis

scientific article published on 01 December 2005

Aerosol Foam Formulation of Fixed Combination Calcipotriene Plus Betamethasone Dipropionate is Highly Efficacious in Patients With Psoriasis Vulgaris: Pooled Data From Three Randomized Controlled Studies

scientific article

Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial

scientific article published on January 2015

Afamelanotide for Erythropoietic Protoporphyria

scientific article published on July 2015

Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate

scientific article

Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis.

scientific article

Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing

scientific article published on 15 August 2015

Amyloidosis cutis dyschromica associated with atypical Parkinsonism, spasticity and motor weakness in a Pakistani female ⬇️

scientific article published on June 7, 2011

An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis

scientific article published on 01 July 2005

An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis

scientific article published in June 2003

An investigator-initiated, double-blind, vehicle-controlled pilot study: assessment for tachyphylaxis to topically occluded halobetasol 0.05% ointment in the treatment of psoriasis

scientific article published on 11 June 2014

An open-label study of the safety and efficacy of limited application of fluticasone propionate ointment, 0.005%, in patients with atopic dermatitis of the face and intertriginous areas

scientific article published in November 2002

An update on generalized pustular psoriasis

scientific article published on 05 September 2019

An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up

scientific article published on March 1, 2012

Annual screening for tuberculosis in patients on TNF-alfa antagonists

scientific article published in September 2015

Apremilast and systemic retinoid combination treatment for moderate to severe palmoplantar psoriasis

scientific article published on 01 July 2020

Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey

scientific article published on 13 August 2007

Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic ⬇️

scientific article published on December 29, 2010

Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face

scientific article published in May 2017

Association of Pityrosporum orbiculare (Malassezia furfur) with seborrheic dermatitis in patients with acquired immunodeficiency syndrome (AIDS)

scientific article published on 01 May 1989

Association of patient-reported psoriasis severity with income and employment

scientific article published on 29 August 2007

Atopic dermatitis

scientific article published on 01 June 1998

Atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity

scientific article published in 2017

Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab

scientific article published on 17 August 2018

Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.

scientific article published in June 2011

Bimekizumab 3-year Maintenance of Response in Week 16 Responders with Moderate to Severe Plaque Psoriasis: Results from Five Phase 3/3b Trials

scholarly article published on 16 January 2024

Bimekizumab 3-year Safety and Tolerability in Moderate to Severe Plaque Psoriasis: Long-term Pooled Analysis from Five Phase 3/3b Trials

scholarly article published on 16 January 2024

Biological treatment for psoriasis and the risk of herpes zoster: Results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

scientific article published on 5 April 2018

Biologics and Psoriasis: The Beat Goes On

scientific article published on 01 November 2018

Biologics for psoriasis: a translational research success story

scientific article published on 01 May 2015

Biologics in combination with nonbiologics: efficacy and safety

scientific article published in January 2004

Biopsy techniques: shave, punch, or excision?

scientific article published on 01 January 2014

Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells

scientific article

Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseases

scientific article published on 18 December 2018

Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failed

scientific article published on 10 May 2019

Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis

scholarly article published on 23 February 2018

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

scientific article

Calcinosis cutis in a patient with eosinophilia-myalgia syndrome: case report

scientific article published on 01 June 2006

Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: Effects on the duration of improvement ⬇️

scientific article published on 01 September 1998

Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial

scientific article published on January 1, 2013

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study

scientific article

Calcipotriol Plus Betamethasone Dipropionate Foam is Effective in Patients with Moderate-to-Severe Psoriasis: Post-Hoc Analysis of the PSO-ABLE Study

scholarly article published on 23 February 2018

Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies

scientific article published on 01 April 2007

Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasis.

scientific article published in April 2009

Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies.

scientific article

Case studies in severe psoriasis: A clinical strategy ⬇️

scientific article published on January 1, 2003

Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: Results Through 48 Weeks of a Phase 3, Multicenter, Randomized, Double-Blinded, Etanercept- and Placebo-Controlled Study (CIMPACT).

scientific article published on 13 April 2018

Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials

scientific article published on 14 October 2018

Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry

scientific article published on 21 January 2020

Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry

scientific article published on 16 October 2017

Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody

scientific article published on 01 November 2002

Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis

scientific article

Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials

scientific article published on 07 October 2020

Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part I.

scientific article

Clinical management of psoriasis: principles and practice.

scientific article

Clinical meaningfulness of complete skin clearance in psoriasis.

scientific article

Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis

article published in 2013

Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.

scientific article published in May 2005

Collagen alterations in chronically sun-damaged human skin

scientific article published on 01 December 1993

Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry

scientific article published on 01 August 2019

Combination therapy to treat moderate to severe psoriasis.

scientific article published on March 2004

Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center

scientific article published in October 2013

Combining systemic retinoids with biologic agents for moderate to severe psoriasis

scientific article published on May 2008

Combining the new biologic agents with our current psoriasis armamentarium

scientific article

Comparable efficacy and safety of brodalumab in obese and nonobese patients with psoriasis: analysis of two randomized controlled trials

scientific article published on 16 October 2019

Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]).

scientific article published on 4 February 2016

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

scientific article published in The Lancet

Comparison of urinary 8-hydroxy-2'-deoxyguanosine in patients treated with topical corticosteroids, UV-B, and psoralen UV-A therapies

scientific article published on 01 June 2000

Compatibility of topical therapies for psoriasis: challenges and innovations.

scientific article published on January 2007

Consensus Workshop on the Toxic Effects of Long-term PUVA Therapy

article

Consensus guidelines for the management of plaque psoriasis.

scientific article

Continued treatment with secukinumab is associated with high retention or regain of response

scientific article published on 17 July 2019

Correction to: Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence

scientific article published on 18 May 2020

Cost of atopic dermatitis and eczema in the United States

scientific article published in March 2002

Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.

scientific article published in April 2003

Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial

scientific article published on 03 July 2019

Crisaborole Topical Ointment, 2%: A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic Dermatitis

scientific article published on April 2016

Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series

scientific article published in October 2004

Cutaneous reactions to vitamin K1 injections

scientific article published on 01 February 1993

Cutaneous ulceration caused by methotrexate

scientific article

Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10

scientific article

Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference

scientific article

Cyclosporine consensus conference: With emphasis on the treatment of psoriasis ⬇️

scientific article published on 01 September 1998

Daily UVB exposure levels in high-school students measured with digital dosimeters

scientific article published on December 2003

Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatment

scientific article published on 31 May 2018

Dermatologic findings in two patients with COVID-19

scientific article published on 28 April 2020

Determination of desmosines in elastin-related skin disorders by isocratic high-performance liquid chromatography

scientific article published on 01 February 1990

Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials

scholarly article published on 16 January 2024

Development of the US PSORIQoL: a psoriasis-specific measure of quality of life

scientific article

Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review

scientific article published on 01 August 2018

Disease burden and quality of life in psoriasis patients with and without comorbid psoriatic arthritis: results from National Psoriasis Foundation panel surveys

scientific article published in March 2015

Diseases of the dermis

scientific article published on 01 August 1990

Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease

scientific article published on 12 February 2014

Do we need more psoriasis therapies?

scientific article

Does Treatment of Psoriasis Reduce Cardiovascular Comorbidities?

scientific article

Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapies

scientific article

Dupilumab as a treatment for generalized idiopathic pruritus: a report of two cases

scientific article published on 28 December 2019

Early Onset of Clinical Improvement with Ixekizumab in a Randomized, Open-label Study of Patients with Moderate-to-severe Plaque Psoriasis.

scientific article

Early Relief of Pruritus in Atopic Dermatitis with Crisaborole Ointment, A Non-steroidal, Phosphodiesterase 4 Inhibitor

scientific article published on 24 January 2018

Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

scientific article published on 01 December 2018

Effect of UV-B phototherapy on plasma HIV type 1 RNA viral level: a self-controlled prospective study

scientific article published on 01 August 1998

Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study.

scientific article published on 21 October 2017

Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris ⬇️

scientific article published on November 1, 1997

Effects of topical preparations on the erythemogenicity of UVB: implications for psoriasis phototherapy

scientific article published on 01 March 1995

Effects of ultraviolet B exposure on the expression of proliferating cell nuclear antigen in murine skin

scientific article published on November 2004

Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study

scientific article published on August 2017

Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

scientific article published on 04 February 2020

Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL.

scientific article published in February 2018

Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups

scientific article published on 01 October 2019

Efficacy and Safety of Ixekizumab Over 4 Years of Open-Label Treatment in a Phase 2 Study in Chronic Plaque Psoriasis.

scientific article published on 10 April 2018

Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase 3 trials

article

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.

scientific article published on 7 July 2016

Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial

scientific article published on 15 January 2018

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

scientific article published in The Lancet

Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata

scientific article published on 18 August 2018

Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris

scientific article

Efficacy and safety of ustekinumab in adolescents

scientific article published on 19 September 2016

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

scientific article

Efficacy of Fixed-combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam for Scalp Plaque Psoriasis: Additional Analysis of a Phase II, Randomized Clinical Study

scientific article published on 01 May 2020

Efficacy of a Once-Daily Fixed Combination Halobetasol (0.01%) and Tazarotene (0.045%) Lotion in the Treatment of Localized Moderate-to-Severe Plaque Psoriasis

scientific article published on 01 March 2019

Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study

scientific article published on 01 December 2019

Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials

scientific article published on 01 October 2019

Elastase digestion of normal and pseudoxanthoma elasticum lesional skin elastins

scientific article published on 01 October 1991

Elastase-like protease and elastolytic activities expressed in cultured dermal fibroblasts derived from lesional skin of patients with pseudoxanthoma elasticum, actinic elastosis, and cutis laxa

scientific article published on 01 August 1988

Erratum to: Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.

scientific article published in August 2017

Evaluating Costs of Biologic Drugs for the Treatment of Moderate-to-Severe Psoriasis in the United States

scholarly article

Evaluating the economic burden of psoriasis in the United States

scientific article published on 14 April 2015

Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis

scientific article

Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies

scientific article published on 29 September 2017

Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis

scientific article published on 01 November 2004

Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism

scientific article published on 20 November 2015

Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the international psoriasis council ⬇️

scientific article published on May 13, 2011

Fatal influenza A(H1N1) respiratory tract infection in a patient having psoriasis treated with infliximab

scientific article

Fixed Combination Aerosol Foam Calcipotriene 0.005% (Cal) Plus Betamethasone Dipropionate 0.064% (BD) is More Efficacious than Cal or BD Aerosol Foam Alone for Psoriasis Vulgaris: A Randomized, Double-blind, Multicenter, Three-arm, Phase 2 Study

scientific article published on February 2016

Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile.

scientific article published on 12 December 2016

Fixed-Combination Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam Is Well Tolerated in Patients with Psoriasis Vulgaris: Pooled Data from Three Randomized Controlled Studies

scientific article

From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis

scientific article

From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies

scientific article

From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis

scientific article published on 22 November 2016

From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis.

scientific article published on 5 November 2007

Genital lentigines in a 6-year-old boy with a family history of Cowden's disease: clinical and genetic evidence of the linkage between Bannayan-Riley-Ruvacalba syndrome and Cowden's disease

scientific article published on 02 May 2001

Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways

scientific article published on 20 December 2019

Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies

scientific article

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

scientific article

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics

scientific article published on May 2008

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy

scientific article published on 7 October 2009

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

scientific article published on 03 June 2009

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

scientific article published on 08 February 2011

Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque Psoriasis

scientific article published on 01 December 2018

Hat-wearing patterns in persons attending baseball games

scientific article

Herpes zoster in psoriasis patients treated with tofacitinib

scientific article published on August 2017

Hyaluronic acid and dermatan sulfate in non-lesional pseudoxanthoma elasticum skin

scientific article published on 01 June 1995

IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies

scientific article

Iatrogenic effects of biologics for psoriasis.

scientific article

Identification of Possible Reactive Oxygen Species Involved in Ultraviolet Radiation-Induced Oxidative DNA Damage ⬇️

scientific article published on 01 January 1997

Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials

scientific article

Immunogenicity and skin clearance recapture in clinical studies of brodalumab

scientific article published on 05 June 2019

Impact of Baseline Disease Severity Over 26 and 52 Weeks of Treatment with Calcitriol Ointment 3µg/g in Patients with Mild-to-moderate Plaque Psoriasis ⬇️

scientific article published on February 1, 2012

Impact of Previous Biologic Use on Efficacy and Safety of Brodalumab and Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis: Integrated Analysis of AMAGINE-2 and AMAGINE-3.

scientific article published on 28 February 2018

Impact of ixekizumab treatment on skin-related personal relationship difficulties in moderate-to-severe psoriasis patients: 12-week results from two Phase 3 trials

scientific article published on 2 June 2017

Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry

Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendations.

scientific article published in October 2010

In regards to Girard et a.l Occurrence of vismodegib-induced cramps (muscular spasms) in the treatment of basal cell carcinoma: A prospective study in 30 patients

scientific article published on 17 September 2018

In response to “Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: Risk or opportunity?” ⬇️

scientific article published on 01 April 2011

In the clinic. Psoriasis

scientific article published on August 2011

Indications and limitations of afamelanotide for treating vitiligo-reply.

scientific article published in March 2015

Induction of 8-oxo-7,8-dihydro-2'-deoxyguanosine by ultraviolet radiation in calf thymus DNA and HeLa cells

scientific article published on 01 January 1997

Infectious complications of erythrodermic psoriasis

scientific article published on 01 May 1996

Infrared camera evaluation of the cooling effect of triamcinolone acetonide aerosol

scientific article

Ingenol Mebutate Gel for Actinic Keratosis ⬇️

scientific article published on March 15, 2012

Innovations in the treatment of psoriasis

scientific article published in July 2004

Interleukin-23 blockade: another breakthrough in the treatment of psoriasis

scientific article published on 04 July 2019

Interventions for nail psoriasis

scientific article (publication date: 31 January 2013)

Interventions for nail psoriasis

scientific article

Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis

scholarly article published on 16 January 2024

Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice ⬇️

scientific article published on 01 August 1998

Itch relief in patients with psoriasis: effectiveness of calcipotriol plus betamethasone dipropionate foam

scientific article published on 01 April 2019

Itch: an under-recognized problem in psoriasis

scientific article published on 10 May 2019

Item-level psychometric properties for a new patient-reported psoriasis symptom diary

scientific article published on September 2013

Ixekizumab sustains high level of efficacy and favourable safety profile over 4 years in patients with moderate psoriasis: results from UNCOVER-3 study

scientific article published on 07 November 2019

JOINT AAD-NPF GUIDELINES OF CARE FOR THE MANAGEMENT OF PSORIASIS WITH SYSTEMIC NON-BIOLOGICAL THERAPIES

scientific article published on 28 February 2020

Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures

scientific article published on 30 July 2020

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities

scientific article published on 13 February 2019

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics

scientific article published on 13 February 2019

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients

scientific article published on 05 November 2019

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy

scientific article published on 25 July 2019

Kaposi's sarcoma and acquired immunodeficiency syndrome. Postmortem findings in twenty-four cases

scientific article published on 01 February 1987

L-Carnitine Reduces Muscle Cramps in Patients taking Vismodegib

scholarly article published on 9 March 2018

Large inflamed facial cysts in teenagers

scientific article published on 19 September 2020

Letter in response to Egeberg A, Bryld LE, Skov L, Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis

Long-Term Efficacy of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: Data from a Pivotal Phase 3 Clinical Trial

scholarly article published on 23 February 2018

Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses ⬇️

scientific article published on June 1, 2013

Long-term durability and dose escalation patterns in infliximab therapy for psoriasis

scientific article published on 31 December 2013

Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator-controlled phase 3 AMAGINE-2 trial

scientific article published on 05 June 2019

Long-term efficacy and safety of ixekizumab: 5-year analysis of the UNCOVER-3 randomized controlled trial

scientific article published on 27 November 2020

Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks

scientific article published on 18 July 2019

Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial

scientific article published on 01 January 2005

Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up

scientific article published on 22 March 2015

Long-term management of scalp psoriasis: perspectives from the international psoriasis council ⬇️

scientific article published on June 5, 2012

Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials.

scientific article

Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up

scientific article published on 01 April 2013

Long-term safety results from a phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis

scientific article published on 15 September 2018

Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology

scientific article

Magnesium supplementation in the treatment of pseudoxanthoma elasticum: A randomized trial

scientific article published on 28 February 2019

Malignancy Rates in Brodalumab Clinical Studies for Psoriasis

scientific article published on 23 March 2020

Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update.

scientific article published on 19 December 2017

Mammographic findings in pseudoxanthoma elasticum

scientific article published on 01 March 2003

Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation

scientific article published in February 2018

Melkersson-Rosenthal syndrome successfully treated with adalimumab

scientific article published in February 2018

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference

scientific article published on May 2009

Methotrexate and psoriasis: Consensus conference ⬇️

scientific article published on 01 June 2011

Moderate-to-severe atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity

scientific article published on 20 September 2017

Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6.

scientific article published in September 2005

More on PML in Patients Treated with Dimethyl Fumarate

scientific article published on 01 January 2016

Multiple hamartoma syndrome

scientific article published on 01 August 1987

National Psoriasis Foundation clinical consensus on disease severity

scientific article

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

scientific article published on 04 March 2008

National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents

scientific article published on 15 May 2008

New biologics for psoriasis and psoriatic arthritis.

scientific article published on January 2009

New developments in the treatment of psoriasis

scientific article published on 01 May 2002

New horizons in the management of psoriasis: introduction

scientific article published on 01 February 1998

Newly available treatments for psoriatic arthritis and their impact on skin psoriasis

scientific article

No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis

scientific article published on 08 June 2020

Nonstandard and off-label therapies for psoriasis

scientific article

Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation ⬇️

scientific article published on 07 August 2010

Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis ⬇️

scientific article published on 01 May 1998

Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail ⬇️

scientific article published on 01 June 1998

One-Year Pharmacovigilance Update of Brodalumab

scientific article published on 01 August 2020

Onset of Action of Antipsoriatic Drugs for Moderate-to-Severe Plaque Psoriasis: An Update

scientific article published on 01 March 2019

Onset of Action of Biologics in Patients With Moderate-to-Severe Psoriasis

scientific article published in March 2017

Optimizing topical therapies for treating psoriasis: a consensus conference

scientific article published on September 1, 2010

Oral phosphate binders in the treatment of pseudoxanthoma elasticum

scientific article

Overview on desonide 0.05%: a clinical safety profile.

scientific article

PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in Psoriasis

scientific article published on 23 September 2020

PUVA (8-methoxy-psoralen plus ultraviolet A) induces the formation of 8-hydroxy-2'-deoxyguanosine and DNA fragmentation in calf thymus DNA and human epidermoid carcinoma cells

scientific article published on 01 July 1999

Pathways to managing atopic dermatitis: consensus from the experts

scientific article published on July 2013

Patient education and regular surveillance results in earlier diagnosis of second primary melanoma

scientific article published on 01 June 2007

Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey.

scientific article

Patient-reported impact of chronic urticaria compared with psoriasis in theUnited States

scientific article

Patients with Psoriatic Arthritis at Biologic Therapy Switch: The CorEvitas Psoriasis Registry

scholarly article published on 16 January 2024

Pediatric Psoriasis Comorbidity Screening Guidelines.

scientific article published on 17 May 2017

Pemphigus vulgaris after initiation of psoralen and UVA therapy for psoriasis

scientific article published on 01 April 1994

Periumbilical pseudoxanthoma elasticum associated with chronic renal failure and angioid streaks—apparent regression with hemodialysis ⬇️

scientific article published on 01 August 1998

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

scientific article published on October 2015

Phototherapy in dermatology: A call for action

scientific article published in June 2015

Physician perceptions and experience of current treatment in actinic keratosis.

scientific article published on 27 July 2014

Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey

scientific article published on 16 April 2015

Pilot, multicenter, double-blind, randomized placebo-controlled bilateral comparative study of a combination of calcipotriene and nicotinamide for the treatment of psoriasis

scientific article published on November 2010

Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study

scientific article published in November 2004

Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses

scientific article

Post-Hyaluronic Acid Filler Reaction Treated With Abrocitinib: A Case Report

scholarly article

Potential complications associated with the use of biologic agents for psoriasis

scientific article published on April 2007

Prevalence and awareness of actinic keratosis: Barriers and opportunities ⬇️

scientific article published on January 1, 2013

Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994

scientific article published on 01 February 1996

Prominent mental (chin) crease: a new sign of pseudoxanthoma elasticum

scientific article published in April 2003

Proven efficacy of tacrolimus for facial and intertriginous psoriasis

scientific article published in September 2005

Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter

scientific article

Psoriasis

scientific article published on 01 April 2003

Psoriasis

scientific article published on 01 July 1998

Psoriasis

scientific article published on 01 April 2004

Psoriasis

scientific article published on 01 April 2018

Psoriasis

scientific article published on 24 November 2016

Psoriasis Therapy: Breakthroughs in Pharmacogenomics or in Pharmacology?

scientific article published in December 2016

Psoriasis and stress

scientific article published in January 1998

Psoriasis and the metabolic syndrome

scientific article

Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation

scientific article published on 31 July 2009

Psoriasis in the elderly: From the Medical Board of the National Psoriasis Foundation ⬇️

scientific article published on April 15, 2011

Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists

scientific article published on 18 April 2008

Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections

scientific article published on 11 July 2018

Psoriasis: Which therapy for which patient: Psoriasis comorbidities and preferred systemic agents

scientific article published on 11 July 2018

Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials

scientific article published on 3 October 2017

Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis

scientific article

Rapid Reduction and Free or Almost Free of Itch Response With Oral Difelikefalin in Subjects With Notalgia Paresthetica and Moderate-to-Severe Pruritus

scholarly article published on 16 January 2024

Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3).

scientific article published on August 2017

Reaching complete or near-complete resolution of psoriasis: benefit and risk considerations

scientific article

Reactive angioendotheliomatosis and sarcoidosis

scientific article published on 01 December 2002

Recapture Rate of Brodalumab in Patients With a Lapse in Treatment

scientific article published on 01 April 2020

Recent advances in medical dermatology

scientific article published on October 2007

Reduced burning and stinging associated with topical application of lactic acid 10% with strontium versus ammonium lactate 12%

scholarly article by Madelaine Haddican et al published 1 May 2013 in Cutis

Reduced degree of irritation during a second cycle of ingenol mebutate gel 0.015% for the treatment of actinic keratosis

scientific article published in January 2015

Regression Analysis of Local Skin Reactions to Predict Clearance of Actinic Keratosis on the Face in Patients Treated With Ingenol Mebutate Gel: Experience from Randomized Controlled Trials

scientific article published in February 2017

Relapse, rebound, and psoriasis adverse events: an advisory group report.

scientific article

Reply to "COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution"

scientific article published on 10 April 2020

Reply to 'complementary data for long-term infliximab use in psoriasis'

scientific article published on 01 September 2014

Reply to Research Letter

scientific article published on 29 July 2020

Reply to: "Biologics for psoriasis during COVID-19 outbreak"

scientific article published on 10 April 2020

Reply to: "Comment on 'Magnesium supplementation in the treatment of pseudoxanthoma elasticum: Is magnesium oxide the best choice?'"

scientific article published on 04 July 2019

Reply to: "Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials".

scientific article published in March 2018

Reply to: "Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors".

scientific article

Research gaps in psoriasis: opportunities for future studies.

scientific article published on 11 October 2013

Retrospective analysis of the treatment of psoriasis of the palms and soles ⬇️

scientific article published on January 1, 2003

Retrospective study of the efficacy of narrowband UVB and acitretin.

scientific article published in January 2003

Review of safety and efficacy of approved systemic psoriasis therapies

scientific article published on 23 September 2018

Review of therapy of psoriasis: the prebiologic armamentarium

scientific article published in October 2004

Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation

scientific article published on 22 October 2011

Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis

scientific article

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

scientific article published on 13 May 2015

Risk of Skin Disorders in Patients with Celiac Disease: A Population-Based Cohort Study

scientific article published on 31 October 2020

Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry.

scientific article published on 8 September 2017

Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial

scientific article published on 01 July 2020

Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of two Phase 3 randomized controlled trials

scientific article published on 31 March 2018

Safety in moderate-to-severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti-tuberculosis treatments concomitantly: Results from pooled Phase 3 VOYAGE 1 & VOYAGE 2 trials

scientific article published on 14 April 2020

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure

scientific article published on 20 November 2019

Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials

scientific article published on 25 May 2020

Sarecycline as a Potential Treatment for Steroid-Induced Rosacea/Perioral Dermatitis: A Case Report

scholarly article

Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials

scientific article published on 11 February 2016

Secukinumab in plaque psoriasis--results of two phase 3 trials

scientific article published on 9 July 2014

Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results)

article

Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept

scientific article published on 10 January 2017

Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial

scientific article published on 30 January 2020

Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cells ⬇️

scientific article published on October 28, 2003

Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data.

scientific article

Should biologics for psoriasis be interrupted in the era of COVID-19?

scientific article published on 18 March 2020

Sterility of refrigerated injectable collagen syringes after injection of patient

scientific article published on 01 December 1992

Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3).

scientific article published on 19 October 2016

Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice

scientific article published on 01 February 2019

Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment

scientific article published on 7 March 2017

TNF inhibitors for psoriasis

scientific article published on 01 September 2018

Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas

scientific article published in April 2003

Tacrolimus ointment in the treatment of eyelid dermatitis.

scientific article

Tacrolimus ointment is effective for facial and intertriginous psoriasis

scientific article

Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies

scientific article published in May 2005

Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis

scientific article published on 01 October 1998

Tazarotene Revisited: Safety and Efficacy in Plaque Psoriasis and Its Emerging Role in Treatment Strategy

scientific article published on 01 December 2018

Tazarotene Revisited: Safety and Efficacy in Plaque Psoriasis and Its Emerging Role in Treatment Strategy

scientific article published in December 2018

Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks ⬇️

scientific article published on May 1, 2003

Tazarotene in combination with topical corticosteroids

scientific article published on 01 October 1998

The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2)

scientific article published on 01 August 2020

The Efficacy of Afamelanotide and Narrowband UV-B Phototherapy for Repigmentation of Vitiligo ⬇️

scientific article published on January 1, 2013

The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists

scientific article published on 01 July 2018

The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument

scientific article published on 4 April 2013

The benefit/risk profile of TNF-blocking agents: findings of a consensus panel

scientific article

The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study

scientific article published on 2 August 2017

The effect of weight on the efficacy of biologic therapy in patients with psoriasis

scientific article published on 20 December 2007

The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis

scientific article published on 01 January 2006

The efficacy of secukinumab with continued use in the treatment of psoriasis ⬇️

scholarly article

The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasis

scientific article published in November 2007

The role of human papillomavirus in common skin conditions: current viewpoints and therapeutic options

scientific article

The state and consequences of dermatology drug prices in the United States

scientific article published on 23 June 2016

The use of alefacept in the treatment of psoriasis

scientific article published on September 2003

The use of the 308-nm excimer laser for the treatment of psoriasis

scientific article

The use of the 308-nm excimer laser for the treatment of vitiligo

scientific article published in July 2004

Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)

scientific article published on 26 September 2019

Tildrakizumab efficacy, drug survival, and safety are comparable in patients with psoriasis with and without metabolic syndrome: Long-term results from two phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)

scientific article published on 19 September 2020

Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post-hoc analysis through 64 weeks from reSURFACE 1 trial

scientific article published on 26 September 2020

Tinea versicolor treated with terbinafine 1% solution

scientific article published on 01 November 1999

Topical calcipotriene in combination with UVB phototherapy for psoriasis

scientific article published on 01 April 1997

Topical corticosteroids in psoriasis: strategies for improving safety

scientific article published on 03 July 2009

Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis ⬇️

scientific article published on January 1, 2003

Translating psoriasis guidelines into practice: Important gaps revealed

scientific article published on 14 January 2016

Treatment of COVID-19 induced chilblains with topical nitroglycerin

scientific article published on 20 October 2020

Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence

scientific article published on 02 April 2020

Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation

scientific article published on 08 August 2009

Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation

scientific article published on January 2009

Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept

scientific article published on 01 March 2006

Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation

scientific article published on 07 October 2009

Treatment of psoriasis with crisaborole

scientific article published on 08 June 2018

Treatment of psoriasis. Part 1. Topical therapy and phototherapy

scientific article

Treatment of psoriatic arthritis with etanercept, a tumour necrosis factor antagonist

scientific article

Treatment of pustular psoriasis: From the Medical Board of the National Psoriasis Foundation ⬇️

scientific article published on May 18, 2012

Treatment of recalcitrant granuloma annulare (GA) with adalimumab: A single-center, observational study

scientific article published on 06 November 2015

Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation

scientific article published on 17 April 2009

Treatment of vitiligo using the 308-nm excimer laser

scientific article published on June 2006

Treatments for psoriasis and the risk of malignancy

scientific article

Trial of Roflumilast Cream for Chronic Plaque Psoriasis

scientific article published on 01 July 2020

Tumour necrosis factor-α blockers in the treatment of psoriasis ⬇️

scientific article published on 01 June 2010

Twice-weekly topical calcipotriene / betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)

scientific article published on 17 September 2020

US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey

scientific article published on 30 December 2015

US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry

scientific article published on 29 April 2019

UV-A and UV-B Penetration of Normal Human Cadaveric Fingernail Plate ⬇️

scientific article published on December 20, 2010

Ultraviolet radiation in alpine skiing: magnitude of exposure and importance of regular protection

scientific article published on 01 January 2003

Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011.

scientific article published in October 2013

Use and abuse of topical corticosteroids in infections of the skin and related structures.

scientific article

Use of 308 nm excimer laser for the treatment of chronic hand and foot eczema

scientific article

Use of Ber-EP4 protein in recurrent metastatic basal cell carcinoma: a case report and review of the literature

scientific article published in August 2004

Use of dose-exposure-response relationships in Phase 2 and Phase 3 guselkumab studies to optimize dose selection in psoriasis

scientific article published on 06 June 2019

Use of etanercept in the dermatology setting. A review

scientific article

Ustekinumab as therapy for psoriasis in a 2-year-old girl

scientific article published on 16 September 2015

Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial

scientific article published on 9 November 2009

Utilization of the validated Psoriasis Epidemiology Screening Tool (PEST) to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry ⬇️

scientific article published on 05 March 2019

Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczema

scientific article published in January 2003

Water content and other aspects of brittle versus normal fingernails

scientific article published on 06 April 2007

What Lies Beneath the Face Value of a BOX WARNING: A Deeper Look at Brodalumab

scientific article published on 01 August 2018

What the National Psoriasis Foundation means to dermatologists and our patients

scientific article published on 01 September 2008

What's New in Psoriasis

scientific article published on 01 April 2019

Paulina is supported by:

About Paulina

Help